» Authors » Beibei Lin

Beibei Lin

Explore the profile of Beibei Lin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 156
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo X, Zhu Z, Yang T, Lin B, Huang J, Deng J, et al.
IEEE Trans Pattern Anal Mach Intell . 2025 Mar; PP. PMID: 40031568
Gait benchmarks empower the research community to train and evaluate high-performance gait recognition systems. Even though growing efforts have been devoted to cross-view recognition, academia is restricted by current existing...
2.
Xu X, Wang Q, Guo K, Xu J, Lu Y, Chen H, et al.
J Exp Clin Cancer Res . 2025 Feb; 44(1):67. PMID: 39994810
Background: Targeting oncogenic histone modification by histone deacetylase inhibitors (HDACis) demonstrates promising prospects in clinical cancer treatment, whereas a notable proportion of patients cannot benefit from HDACi therapy. This study...
3.
Han Q, Lin B, Liu Z, Li M, Luo Z, Xie X, et al.
ChemistryOpen . 2025 Jan; e202400433. PMID: 39778026
5-Enolpyruvylshikimate-3-phosphate synthase (EPSPS) catalyzes the conversion of 5-enolpyruvate (PEP) and shikimic acid phosphate (S3P) to 5-enolpyruvylshikimic acid-3-phosphate (EPSP), releasing inorganic phosphate. This reaction is the sixth step of the shikimate...
4.
Shi H, Lin B, Zheng M, Gan F, Lin Z, Xin X, et al.
Bioresour Bioprocess . 2025 Jan; 12(1):2. PMID: 39776300
Aspergillus oryzae is a widely used host for heterologous expression of fungal natural products. However, the vectors previously developed are not convenient for use and screening positive transformants by PCR...
5.
Lin B, Lin P, Zhang X, Liao Y, Yu Y, Xu X, et al.
Int J Nanomedicine . 2025 Jan; 19:14105-14124. PMID: 39764187
Background: Developing carrier-free nanomedicines via self-assembly of two antitumor drug molecules is a potential strategy for enhancing the combination treatment of tumors. Similarly, conventional chemotherapy combined with photodynamic therapy may...
6.
Zhang X, Wang H, Lin B, Meng X, Deng J
Front Vet Sci . 2024 Dec; 11:1459001. PMID: 39664892
Introduction: This study was conducted to evaluate the effects of dietary AX inclusion on the chemical barrier, antioxidant function and intestinal microbiome of rainbow trout. Methods: Five isoproteic and isolipidic...
7.
Liu B, Lin B, Su H, Sheng X
Phys Chem Chem Phys . 2024 Sep; 26(42):26677-26692. PMID: 39347748
Enzymatic capture and conversion of carbon dioxide (CO) into value-added chemicals are of great interest in the field of biocatalysis and have a positive impact on climate change. The quantum...
8.
Mao Q, Lin B, Zhang W, Zhang Y, Cao Q, Xu M
Front Pharmacol . 2024 Apr; 15:1371574. PMID: 38576492
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, resulting in a huge medical burden worldwide. Accumulating evidence suggests that the gut microbiome and bile acids play...
9.
Xu M, Zhang W, Lin B, Lei Y, Zhang Y, Chen B, et al.
Nutr Rev . 2024 Mar; 83(2):e65-e73. PMID: 38553410
Objective: The aim of this meta-analysis was to evaluate the efficacy of probiotics supplementation in patients with IBD. Data Sources: Randomized controlled trials (RCTs) evaluating the efficacy of probiotics in...
10.
Hao H, Xu Y, Chen R, Qi S, Liu X, Lin B, et al.
Biotech Histochem . 2023 Nov; 99(1):33-43. PMID: 38018995
We investigated possible protective effects of chlorogenic acid (CGA) against cyclophosphamide (CP) induced hepatic injury in mice. We measured aminotransferase alanine transaminase (ALT) and aspartate transaminase (AST) levels in the...